Paper Details

  1. Home
  2. Paper Details

The uncharted role of HER2 mutant alleles in breast cancer.

Author: EllisMatthew J, KalraRashi, KavuriShyam M, LimBora

EditorialAn article in which the editor or publisher expresses their opinion or perspective on a particular topic or issue. Its purpose is to convey a specific message or idea to the reader.

Overview

Somatic HER2 mutations are emerging targets for cancer therapy. This discussion focuses on the use of neratinib, a tyrosine kinase inhibitor (TKI), for HER2-mutant metastatic disease. The authors discuss the heterogeneity of responses to neratinib, the role of HER2 mutations in metastatic propensity, and the potential for other agents like poziotinib.
Paper Details　
Original Abstract of the Article :
Somatic HER2 mutations are a novel class of therapeutic targets across different cancer types. Treatment with the tyrosine kinase inhibitor (TKI) neratinib as a single agent continues to be evaluated in HER2-mutant metastatic disease. However, responses are heterogeneous, with frequent early progres...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624202/

データ提供：米国国立医学図書館（NLM）

The Under-Explored Role of HER2 Mutant Alleles in Breast Cancer

This research explores the complex role of HER2 mutant alleles in breast cancer, focusing on their impact on therapeutic response and metastatic propensity. The study highlights the importance of understanding the individual effects of different HER2 mutations on patient outcomes and the need for more personalized treatment approaches.

The authors discuss the challenges of treating HER2-mutant metastatic breast cancer with the tyrosine kinase inhibitor neratinib, noting the heterogeneous responses and frequent early progression. They emphasize the need to further investigate the effects of individual HER2 mutant alleles on therapeutic response and metastatic potential.

Unveiling the Complexities of HER2 Mutations

This research underscores the need for a more nuanced understanding of HER2 mutations in breast cancer. The study calls for further investigation into the specific effects of different HER2 mutant alleles and the development of targeted therapies that can address these variations.

Health and Lifestyle: Understanding Breast Cancer

Breast cancer is a complex disease, and treatment options vary depending on factors such as tumor characteristics and patient health status. This research highlights the importance of personalized medicine and the need to develop more effective and targeted therapies to improve patient outcomes.

Dr.Camel's Conclusion

This research, like a camel traversing a vast and complex desert, delves into the intricate world of HER2 mutations in breast cancer. The study emphasizes the need for a deeper understanding of these mutations to develop more effective and personalized treatments. It reminds us that, in the fight against cancer, continued research and innovation are crucial for finding new solutions and improving the lives of patients.

Date :
  1. Date Completed 2023-11-06
  2. Date Revised 2023-11-06
Further Info :

Pubmed ID

37921670

DOI: Digital Object Identifier

PMC10624202

Related Literature

Article Analysis
・Effects of neratinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.